JP2010520758A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010520758A5 JP2010520758A5 JP2009552983A JP2009552983A JP2010520758A5 JP 2010520758 A5 JP2010520758 A5 JP 2010520758A5 JP 2009552983 A JP2009552983 A JP 2009552983A JP 2009552983 A JP2009552983 A JP 2009552983A JP 2010520758 A5 JP2010520758 A5 JP 2010520758A5
- Authority
- JP
- Japan
- Prior art keywords
- reovirus
- nucleic acid
- residue
- polypeptide
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89442507P | 2007-03-12 | 2007-03-12 | |
| US60/894,425 | 2007-03-12 | ||
| US98956807P | 2007-11-21 | 2007-11-21 | |
| US60/989,568 | 2007-11-21 | ||
| PCT/CA2008/000483 WO2008110004A1 (en) | 2007-03-12 | 2008-03-11 | Reoviruses having modified sequences |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010520758A JP2010520758A (ja) | 2010-06-17 |
| JP2010520758A5 true JP2010520758A5 (enExample) | 2011-04-28 |
| JP5577103B2 JP5577103B2 (ja) | 2014-08-20 |
Family
ID=39758956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009552983A Active JP5577103B2 (ja) | 2007-03-12 | 2008-03-11 | 改変配列を有するレオウイルス |
Country Status (16)
| Country | Link |
|---|---|
| US (5) | US7803385B2 (enExample) |
| EP (2) | EP2952583A1 (enExample) |
| JP (1) | JP5577103B2 (enExample) |
| KR (1) | KR101647843B1 (enExample) |
| CN (1) | CN103710359A (enExample) |
| AR (1) | AR066395A1 (enExample) |
| AU (1) | AU2008226291B2 (enExample) |
| CA (1) | CA2678721C (enExample) |
| DK (1) | DK2132315T3 (enExample) |
| ES (1) | ES2548442T3 (enExample) |
| IL (4) | IL200353A (enExample) |
| MX (2) | MX2009009598A (enExample) |
| SG (1) | SG191602A1 (enExample) |
| TW (1) | TW200904979A (enExample) |
| WO (1) | WO2008110004A1 (enExample) |
| ZA (1) | ZA200905951B (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6136307A (en) * | 1997-08-13 | 2000-10-24 | Oncolytics Biotech Inc. | Reovirus for the treatment of cellular proliferative disorders |
| US6110461A (en) * | 1997-08-13 | 2000-08-29 | Oncolytics Biotech Inc. | Reovirus for the treatment of neoplasia |
| SG191602A1 (en) | 2007-03-12 | 2013-07-31 | Oncolytics Biotech Inc | Reoviruses having modified sequences |
| AU2008316276A1 (en) * | 2007-10-22 | 2009-04-30 | Oncolytics Biotech Inc. | Treatment regime for proliferative disorders |
| TW200950777A (en) * | 2008-05-27 | 2009-12-16 | Oncolytics Biotech Inc | Abrogating proinflammatory cytokine production during oncolytic reovirus therapy |
| US20110086005A1 (en) * | 2008-05-27 | 2011-04-14 | Oncolytics Biotech Inc. | Modulating interstitial pressure and oncolytic viral delivery and distribution |
| MX2010014555A (es) * | 2008-06-26 | 2011-04-27 | Ceva Sante Animale Sa | Reoviridae aviar unico. |
| FR2939807B1 (fr) * | 2008-12-11 | 2010-12-17 | Biomerieux Sa | Nouveau reovirus isole, procedes et kits de detection |
| EP2482825B1 (en) | 2009-10-02 | 2016-11-23 | The Trustees of Columbia University in the City of New York | Piscine reovirus diagnostic compositions |
| CA2819236A1 (en) | 2010-12-02 | 2012-06-07 | Oncolytics Biotech Inc. | Lyophilized viral formulations |
| MX373096B (es) * | 2010-12-02 | 2020-04-27 | Oncolytics Biotech Inc | Formulaciones virales líquidas. |
| EA201391605A1 (ru) * | 2011-04-29 | 2014-02-28 | Онколитикс Байотек Инк. | Способы очистки вирусов с использованием гельпроникающей хроматографии |
| ES2796950T3 (es) | 2013-11-15 | 2020-11-30 | Oncolytics Biotech Inc | Virus oncolíticos y regímenes reforzados para tratamiento de cáncer |
| US9660989B1 (en) | 2014-01-31 | 2017-05-23 | Google Inc. | Internet-wide identity management widget |
| WO2017141942A1 (ja) | 2016-02-16 | 2017-08-24 | 国立大学法人大阪大学 | 線維化を治療するための医薬組成物 |
| WO2019237063A1 (en) * | 2018-06-07 | 2019-12-12 | Emory University | Modified reoviruses, particles, and uses in treating proliferative disorders |
| KR102401077B1 (ko) | 2019-01-25 | 2022-05-24 | 바이로큐어 주식회사 | 다람쥐 섬유종 바이러스 및 리오바이러스를 포함하는 암 예방 또는 치료용 약학적 조성물 |
| US20220193220A1 (en) * | 2019-05-03 | 2022-06-23 | Kansas State University Research Foundation | Immunogenic compositions for novel reassortant mammalian ortheovirus from pigs |
| CN116917468A (zh) * | 2020-12-22 | 2023-10-20 | 百洛克株式会社 | 新型修饰的呼肠孤病毒及其用途 |
| JP2024500164A (ja) * | 2020-12-22 | 2024-01-04 | バイロキュア インコーポレイテッド | 新規な改変レオウイルス及びその用途 |
| US20250154204A1 (en) * | 2021-09-24 | 2025-05-15 | Virocure, Inc. | Novel reovirus-based vaccine platform and use thereof |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US6565831B1 (en) | 1999-02-24 | 2003-05-20 | Oncolytics Biotech Inc. | Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| US6136307A (en) * | 1997-08-13 | 2000-10-24 | Oncolytics Biotech Inc. | Reovirus for the treatment of cellular proliferative disorders |
| US6110461A (en) * | 1997-08-13 | 2000-08-29 | Oncolytics Biotech Inc. | Reovirus for the treatment of neoplasia |
| TWI289158B (en) | 2000-08-10 | 2007-11-01 | Oncolytics Biotech Inc | Method of producing infectious reovirus |
| ES2445704T3 (es) | 2000-11-09 | 2014-03-04 | Oncolytics Biotech Inc. | Métodos para el tratamiento de trastornos celulares proliferativos |
| WO2002043647A2 (en) | 2000-12-01 | 2002-06-06 | University Of Ottawa | Oncolytic virus |
| IL157304A0 (en) | 2001-03-16 | 2004-02-19 | Oncolytics Biotech Inc | Method of extracting virus from cell culture |
| US7163678B2 (en) * | 2002-11-07 | 2007-01-16 | Oncolytics Biotech Inc. | Reovirus for the treatment of ral-mediated cellular proliferative disorders |
| WO2005111200A1 (en) * | 2004-05-17 | 2005-11-24 | Universite De Montreal | Novel strains of reoviruses and methods of uses thereof |
| EP1775343A4 (en) * | 2004-06-24 | 2007-11-14 | Dnavec Research Inc | ANTITUM-AGENT WITH DENDRITIC CELL WITH THE TRANSFECTED RNA VIRUS |
| WO2007099401A2 (en) * | 2005-08-01 | 2007-09-07 | University Technologies International, Inc. | Oncolytic attenuated reoviruses for treatment of proliferative disorders |
| US20100086522A1 (en) | 2006-07-18 | 2010-04-08 | Ottawa Health Research Institute | Disparate suicide carrier cells for tumor targeting of promiscuous oncolytic viruses |
| SG191602A1 (en) | 2007-03-12 | 2013-07-31 | Oncolytics Biotech Inc | Reoviruses having modified sequences |
| TW200950777A (en) * | 2008-05-27 | 2009-12-16 | Oncolytics Biotech Inc | Abrogating proinflammatory cytokine production during oncolytic reovirus therapy |
| CA2819236A1 (en) * | 2010-12-02 | 2012-06-07 | Oncolytics Biotech Inc. | Lyophilized viral formulations |
| MX373096B (es) * | 2010-12-02 | 2020-04-27 | Oncolytics Biotech Inc | Formulaciones virales líquidas. |
-
2008
- 2008-03-11 SG SG2013040027A patent/SG191602A1/en unknown
- 2008-03-11 WO PCT/CA2008/000483 patent/WO2008110004A1/en not_active Ceased
- 2008-03-11 US US12/046,095 patent/US7803385B2/en active Active
- 2008-03-11 ES ES08733587.3T patent/ES2548442T3/es active Active
- 2008-03-11 CA CA2678721A patent/CA2678721C/en active Active
- 2008-03-11 EP EP15176066.7A patent/EP2952583A1/en not_active Withdrawn
- 2008-03-11 MX MX2009009598A patent/MX2009009598A/es active IP Right Grant
- 2008-03-11 EP EP08733587.3A patent/EP2132315B1/en active Active
- 2008-03-11 KR KR1020097019418A patent/KR101647843B1/ko active Active
- 2008-03-11 CN CN201310353609.2A patent/CN103710359A/zh active Pending
- 2008-03-11 DK DK08733587.3T patent/DK2132315T3/en active
- 2008-03-11 JP JP2009552983A patent/JP5577103B2/ja active Active
- 2008-03-12 TW TW097108636A patent/TW200904979A/zh unknown
- 2008-03-12 AR ARP080101017A patent/AR066395A1/es unknown
- 2008-03-14 AU AU2008226291A patent/AU2008226291B2/en active Active
-
2009
- 2009-08-12 IL IL200353A patent/IL200353A/en active IP Right Grant
- 2009-08-27 ZA ZA2009/05951A patent/ZA200905951B/en unknown
- 2009-09-08 MX MX2013013938A patent/MX346950B/es unknown
-
2010
- 2010-08-02 US US12/848,684 patent/US8691241B2/en active Active
-
2012
- 2012-08-30 IL IL221702A patent/IL221702A0/en unknown
- 2012-08-30 IL IL221700A patent/IL221700A0/en unknown
- 2012-08-30 IL IL221701A patent/IL221701A0/en unknown
-
2014
- 2014-02-13 US US14/179,840 patent/US10039827B2/en active Active
-
2018
- 2018-07-03 US US16/027,206 patent/US10596260B2/en active Active
-
2020
- 2020-02-13 US US16/790,114 patent/US11246930B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5577103B2 (ja) | 改変配列を有するレオウイルス | |
| AU782020B2 (en) | Viruses for the treatment of cellular proliferative disorders | |
| CN102858959B (zh) | 溶瘤弹状病毒 | |
| Sinkovics et al. | Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers | |
| ES2212815T3 (es) | Virus citopaticos para la terapia y profilaxis de neoplasia. | |
| CA2494844A1 (en) | Methods and compositions concerning poxviruses and cancer | |
| CN109554353A (zh) | 分离的重组溶瘤痘病毒、药物组合物及其在治疗肿瘤和/或癌症的药物中的用途 | |
| WO2018058258A1 (en) | Recombinant oncolytic viruses for cancer therapy | |
| JP2010527593A (ja) | 変異レオウイルスならびにその作製および使用方法 | |
| JP7144915B2 (ja) | 腫瘍を治療するためのウイルス | |
| CN119709652A (zh) | 溶瘤病毒及其应用 | |
| AU2014292114B2 (en) | Genetically stable oncolytic RNA virus, method of manufacturing and use thereof | |
| CN111714621A (zh) | 转铁蛋白、转铁蛋白受体及其抗体在制备抗SARS-CoV-2病毒的药物中的应用 | |
| CN101137391B (zh) | 重组高效复合干扰素的用途 | |
| WO2019201192A1 (zh) | 一种用于治疗肿瘤的柯萨奇b组病毒 | |
| US20200199624A1 (en) | Recombinant oncolytic virus | |
| US20220296659A1 (en) | Pharmaceutical composition for treatment of tumor or cancer, and application thereof | |
| WO2020238427A1 (zh) | 特异杀伤肿瘤细胞的溶瘤病毒系统及其应用 | |
| AU2009253683B2 (en) | Abrogating proinflammatory cytokine production during oncolytic reovirus therapy | |
| Vorobyev et al. | Oncolytic viruses in the therapy of lymphoproliferative diseases | |
| US20240318147A1 (en) | Recombinant oncolytic virus, and construction method therefor and use thereof | |
| WO2019174610A1 (zh) | 一种溶瘤病毒、合成dna序列及其应用 | |
| US20260053873A1 (en) | Combination therapy of oncolytic virus drugs for cancer treatment | |
| CN115612674B (zh) | 一种溶瘤病毒及其用途 | |
| CN120789239A (zh) | 重组溶瘤病毒和单克隆抗体联用在制备用于治疗hbv阳性肝癌的药物中的应用 |